Comments on: "In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea"

about

Comments on: "In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea"

Item

http://www.wikidata.org/entity/Q58800387

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@en

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@nl

type

Item

label

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@en

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@nl

prefLabel

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@en

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@nl

P1476

Comments on: "In Vitro Safety ...... ments for Erythema of Rosacea"

@en

P2093

Daniel Gil

http://www.w3.org/2001/XMLSchema#string

P2860

Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy

Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment

In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea.

Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.

P304

165-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40268-018-0242-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30078127

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6131125

http://www.w3.org/2001/XMLSchema#string